Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
CANADA FX DEBT - Canadian dollar weakens, benchmark yield climbs

CANADA FX DEBT - Canadian dollar weakens, benchmark yield climbs

ReutersReuters2026/10/08 13:00

The Canadian dollar weakened against the greenback on Thursday, and the yield on benchmark government debt climbed. The loonie CAD= was trading 0.1% lower at C$1.4264 to the greenback, or 70.11 U.S. cents, after trading in a range of 1.4244 to 1.4277. Canadian government 10-year bond yields CA10YT=RR rose 3.9 basis points to 3.987%. The yield on similar U.S. government benchmark debt rose to 5.3199%. U.S. November crude CLc1 futures rose $4.17 to $92.45 a barrel on Thursday.

The Canadian dollar weakened against the greenback on Thursday, and the yield on benchmark government debt climbed.

The loonie CAD= was trading 0.1% lower at C$1.4264 to the greenback, or 70.11 U.S. cents, after trading in a range of 1.4244 to 1.4277.

Canadian government 10-year bond yields CA10YT=RR rose 3.9 basis points to 3.987%. The yield on similar U.S. government benchmark debt rose to 5.3199%.

U.S. November crude CLc1 futures rose $4.17 to $92.45 a barrel on Thursday.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss